There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CS1 maint: Explicit use of et al.
From Self-sufficiency
Pages in category "CS1 maint: Explicit use of et al."
The following 200 pages are in this category, out of 1,030 total.
(previous page) (next page)3
5
A
- Abacavir
- Acetylcysteine
- Aclidinium bromide
- Acrodermatitis chronica atrophicans
- ACTH receptor
- Activated carbon
- Acute pancreatitis
- Adapalene
- Ageratum houstonianum
- Air safety
- ALDH1A1
- Alexithymia
- Alinidine
- Alprazolam
- Amidorphin
- Amiodarone
- Amisulpride
- Amphotericin B
- Ampligen
- Amyloid precursor protein
- Analgesic
- Angina pectoris
- Angiotensin
- Angiotensin II receptor type 1
- Anosognosia
- Anthrax
- Antihypertensive drug
- Apaziquone
- Aplaviroc
- 2-Arachidonyl glyceryl ether
- Arginine vasopressin receptor 1A
- Arginine vasopressin receptor 2
- Aripiprazole
- Artelinic acid
- Arzoxifene
- Asoprisnil
- Aspirin
- Atherosclerosis
- Atomic clock
- Atovaquone
- Atrophic vaginitis
- Attachment-based therapy (children)
B
- Baclofen
- Balanitis
- Bardet–Biedl syndrome
- Benzodiazepine
- Benzodiazepine dependence
- Benzodiazepine withdrawal syndrome
- Berberine
- Bevirimat
- Bifeprunox
- Big dynorphin
- Biomarker (medicine)
- Biphenylindanone A
- Bisoprolol
- Blue field entoptic phenomenon
- Bombesin-like receptor 3
- Bradykinin receptor B1
- Bradykinin receptor B2
- Brain natriuretic peptide
- Brain-specific angiogenesis inhibitor 1
- Brain-specific angiogenesis inhibitor 2
- Brain-specific angiogenesis inhibitor 3
- Bretazenil
- Bronchiolitis
- Bronchiolitis obliterans
- Brushfield spots
- Bupropion
- Burow's solution
- Butter
C
- Calanolide A
- Calcium-sensing receptor
- CALCRL
- Caltrop
- Cancer
- Canine glaucoma
- Cannabidiol
- Cannabinoid
- Cannabinoid receptor type 2
- Cannabinoid receptor type 1
- Cannabis
- Cannabis (drug)
- Cannabis smoking
- Cardiac output
- Cardiomyopathy
- Carney complex
- Caryophyllene
- Catecholamine
- CD97
- Ceftaroline
- CELSR2
- CELSR3
- Central facial palsy
- Cervical conization
- CGS-9896
- Chloramphenicol
- Chlorine
- Chlorothalonil
- Ascending cholangitis
- Cholecystokinin A receptor
- Cholecystokinin B receptor
- Chronic actinic dermatitis
- Chronic cerebrospinal venous insufficiency
- Cidofovir
- Ciprofloxacin
- Cladribine
- Clindamycin
- Clobutinol
- Clopidogrel
- Coagulation factor II receptor
- Cocaethylene
- Codeine
- Coenzyme Q10
- Cognitive behavioral therapy
- Cognitive therapies for dementia
- Colloid
- Combined hyperlipidemia
- Common cold
- Commotio cordis
- Computerized physician order entry
- Congenital generalized lipodystrophy
- Coomassie Brilliant Blue
- Corticotropin releasing hormone receptor 1
- Corticotropin releasing hormone receptor 2
- COX-2 inhibitor
- Cramp
- Criticism of the Food and Drug Administration
- Crohn's disease
- Cryoglobulinemia
- Current mirror
- Cyclophosphamide
- Cyclothiazide
- Cyproheptadine
- Cys-loop receptors
- Cysteinyl leukotriene receptor 1
- Cysteinyl leukotriene receptor 2
- CYT006-AngQb
D
- Dabigatran
- Dairy product
- Dasatinib
- Delayed sleep phase syndrome
- Delta Opioid receptor
- Delusion
- Delusional parasitosis
- Depleted uranium
- Dermatology
- Dermorphin
- Desflurane
- Dextropropoxyphene
- Diabetic cardiomyopathy
- Diabetic retinopathy
- DSM-5
- Dichloroacetic acid
- Digoxin
- Diloxanide furoate
- Dimethyltryptamine
- Docosatetraenoyl ethanolamide
- Domperidone
- Donepezil
- Door-to-balloon
- Dopamine receptor
- Dopamine receptor D1
- Dopamine receptor D2
- Dopamine receptor D3
- Dopamine receptor D4
- Dopamine receptor D5
- Dopamine transporter
- Dopexamine
- Doxycycline
- Drug discovery
- Drug overdose
- Duloxetine